AQB
AquaBounty Technologies, Inc. NASDAQ Listed Jan 11, 2017$0.95
Mkt Cap $3.7M
52w Low $0.61
14.6% of range
52w High $2.95
50d MA $0.94
200d MA $1.07
P/E (TTM)
-0.2x
EV/EBITDA
-3.3x
P/B
—
Debt/Equity
-1.8x
ROE
977.8%
P/FCF
-0.0x
RSI (14)
—
ATR (14)
—
Beta
1.30
50d MA
$0.94
200d MA
$1.07
Avg Volume
33.2K
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
2 Mill and Main Place · Maynard, MA 01754 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | AMC | -0.52 | -3.64 | -600.0% | 0.87 | +3.2% | +2.3% | -1.1% | +4.3% | -2.3% | +4.2% | — |
| Oct 28, 2025 | AMC | -0.62 | -0.36 | +41.9% | 1.46 | -0.7% | -9.6% | +0.8% | -2.3% | -6.2% | -13.1% | — |
| Aug 5, 2025 | AMC | -0.53 | -0.63 | -18.9% | 0.73 | -1.1% | -1.6% | +3.0% | +1.3% | +0.9% | -2.0% | — |
| May 15, 2025 | AMC | -0.61 | 0.16 | +126.2% | 0.77 | -3.0% | +2.0% | +4.9% | +0.6% | +8.8% | -5.6% | — |
| Mar 31, 2025 | AMC | -0.61 | -21.77 | -3469.6% | 0.69 | -5.6% | -3.5% | +3.8% | -4.0% | -3.3% | +2.0% | — |
| Nov 5, 2024 | AMC | -0.89 | -0.88 | +1.1% | 1.15 | -1.7% | -4.3% | +0.0% | -2.7% | -4.7% | +2.9% | — |
| Aug 6, 2024 | AMC | -0.93 | -1.56 | -67.7% | 1.39 | +5.0% | -3.6% | +3.7% | +2.2% | -6.3% | -3.0% | — |
| May 15, 2024 | AMC | -1.42 | -1.53 | -7.7% | 2.00 | -2.5% | -0.5% | -8.5% | +4.4% | +1.6% | -1.0% | — |
| Apr 1, 2024 | AMC | -1.52 | -2.19 | -44.1% | 2.02 | -2.0% | -1.5% | -0.5% | -2.5% | +1.0% | -1.5% | — |
| Nov 7, 2023 | AMC | -2.02 | -1.60 | +20.8% | 2.96 | -4.1% | -9.8% | -2.2% | -11.9% | -6.5% | -1.4% | — |
| Aug 1, 2023 | AMC | -1.60 | -1.80 | -12.5% | 7.00 | +0.3% | -8.3% | -3.1% | -8.7% | -8.8% | +10.0% | — |
| May 4, 2023 | AMC | -1.60 | -1.80 | -12.5% | 10.70 | +0.0% | +1.9% | -1.3% | -0.7% | -0.6% | +0.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2 | Oppenheimer | Maintains | Perform → Perform | — | $2.02 | $1.98 | -2.0% | -1.5% | -0.5% | -2.5% | +1.0% | -1.5% |
| Nov 8 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $2.96 | $2.84 | -4.1% | -9.8% | -2.2% | -11.9% | -6.5% | -1.4% |
| Oct 20 | Oppenheimer | Downgrade | Outperform → Perform | — | $3.69 | $3.60 | -2.4% | -8.4% | +1.5% | -9.0% | -12.5% | -6.2% |
| Aug 2 | Oppenheimer | Maintains | Outperform → Outperform | — | $7.00 | $7.02 | +0.3% | -8.3% | -3.1% | -8.7% | -8.8% | +10.0% |
| Aug 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.00 | $7.02 | +0.3% | -8.3% | -3.1% | -8.7% | -8.8% | +10.0% |
| Aug 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.74 | $8.00 | +3.4% | -9.6% | -8.3% | -3.1% | -8.7% | -8.8% |
| Aug 1 | Oppenheimer | Maintains | Outperform → Outperform | — | $7.74 | $8.00 | +3.4% | -9.6% | -8.3% | -3.1% | -8.7% | -8.8% |
| Jun 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.90 | $7.84 | -0.8% | -9.4% | +1.7% | -1.4% | +4.2% | -3.7% |
| Jun 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| May 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.70 | $10.70 | +0.0% | +1.9% | -1.3% | -0.7% | -0.6% | +0.0% |
| May 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.04 | $10.78 | -2.4% | -3.1% | +1.9% | -1.3% | -0.7% | -0.6% |
| Mar 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.26 | $14.00 | +5.6% | +3.5% | -4.8% | -4.3% | -1.6% | -7.2% |
| Nov 9 | HC Wainwright & Co. | Upgrade | Neutral → Buy | — | $77.20 | $77.90 | +0.9% | +0.5% | -3.1% | -0.8% | +0.5% | -2.7% |
| Nov 8 | HC Wainwright & Co. | Upgrade | Neutral → Buy | — | $74.60 | $74.68 | +0.1% | +3.5% | +0.5% | -3.1% | -0.8% | +0.5% |
| Oct 8 | Roth Capital | Maintains | Buy → Buy | — | $75.60 | $76.40 | +1.1% | +3.2% | -2.1% | +2.6% | +4.1% | -1.2% |
| Jul 1 | Oppenheimer | Maintains | Outperform → Outperform | — | $107.20 | $111.20 | +3.7% | +5.8% | -3.4% | -1.1% | -2.6% | -2.3% |
| Mar 10 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $139.60 | $137.60 | -1.4% | -3.7% | +4.8% | +6.7% | +2.0% | -5.1% |
| Mar 9 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $127.50 | $132.60 | +4.0% | +9.5% | -3.7% | +4.8% | +6.7% | +2.0% |
| Mar 26 | H.C. Wainwright | Maintains | Buy → Buy | — | $36.20 | $36.00 | -0.6% | +1.1% | +0.3% | -8.0% | -3.6% | +1.2% |
| Jan 13 | National Securities | Upgrade | Neutral → Buy | — | $47.72 | $50.80 | +6.5% | +3.1% | +8.1% | -9.4% | +0.8% | -7.6% |
| Jan 12 | National Securities Corporation | Upgrade | Neutral → Buy | — | — | — | — | — | — | — | — | — |
| Mar 6 | National Securities | Maintains | Buy → Buy | — | $42.20 | $42.60 | +0.9% | +4.3% | +1.8% | +118.3% | -26.2% | -3.6% |
| Jun 28 | H.C. Wainwright | Maintains | Buy → Buy | — | $60.80 | $61.60 | +1.3% | -2.6% | +12.5% | -3.9% | +0.6% | -1.6% |
No insider trades available.
8-K · 5.03
! Medium
AquaBounty Technologies, Inc. -- 8-K 5.03: Amendment to Articles / Bylaws
AquaBounty Technologies shifted its fiscal year-end, which may alter the timing of financial reporting and investor communications going forward.
Apr 17
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
AquaBounty's 8-K filing indicates a material announcement, though the specific details are technical; investors should monitor the next earnings report or press release for concrete business impact.
Apr 8
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
AQB entered a material agreement with Univest Securities likely for underwriting or financial advisory services, signaling preparation for capital raising that could dilute shareholders or fund growth initiatives.
Apr 8
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The departure uncertainty surrounding board member Sterling has been resolved with his continued service, reducing potential governance disruption concerns that could have negatively impacted AQB's stock valuation and investor confidence.
Mar 31
8-K · 1.01
!! High
AquaBounty Technologies, Inc. -- 8-K 1.01: Material Agreement
AquaBounty Technologies entered a Securities Purchase Agreement with Univest Securities, potentially securing capital through a direct securities offering to fund operations or growth initiatives.
Feb 12
8-K · 5.02
!!! Very High
AquaBounty Technologies, Inc. -- 8-K 5.02: Executive Change
AquaBounty Technologies' executive change via amended 8-K filing indicates leadership restructuring, though the specific personnel transition details require reviewing the complete filing to assess impact on the genetically modified salmon company's operations and strategy.
Feb 4
Data updated apr 24, 2026 6:39pm
· Source: massive.com